| P50 | author | Afshin Ehsan | Q39879319 |
| P2093 | author name string | Herbert D Aronow | |
| | Barry L Sharaf | |
| | Andrew M Goldsweig | |
| | J Dawn Abbott | |
| | Paul C Gordon | |
| | M Rizwan Sardar | |
| P2860 | cites work | 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement | Q26996071 |
| | Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience | Q28239809 |
| | Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation | Q30317794 |
| | Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry | Q31108661 |
| | Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis | Q33427828 |
| | Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery | Q34144699 |
| | Percutaneous management of vascular access in transfemoral transcatheter aortic valve implantation | Q34179085 |
| | Transcatheter versus surgical aortic-valve replacement in high-risk patients | Q34189672 |
| | True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications | Q34636131 |
| | Duration of red-cell storage and complications after cardiac surgery | Q34763440 |
| | Femoral pseudoaneurysms | Q36441893 |
| | Endovascular management of vascular trauma | Q36632674 |
| | Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. | Q36835976 |
| | Cardiac surgery risk-stratification models | Q37041636 |
| | Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice | Q37499351 |
| | Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications | Q37602850 |
| | Endovascular treatment of complications of femoral arterial access | Q37693800 |
| | Spontaneous retrograde dissection of ascending aorta from descending thoracic aorta--a case review | Q37830185 |
| | Challenges after the first decade of transcatheter aortic valve replacement: focus on vascular complications, stroke, and paravalvular leak | Q38058960 |
| | Management of vascular access in transcatheter aortic valve replacement: part 2: Vascular complications | Q38130774 |
| | Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients | Q38415704 |
| | Transcatheter Aortic Valve Replacement 2016: A Modern-Day "Through the Looking-Glass" Adventure | Q38787753 |
| | Effect of Hospital Volume on Outcomes of Transcatheter Aortic Valve Implantation | Q38887215 |
| | The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients | Q39121041 |
| | Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies | Q39629315 |
| | Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines | Q39752923 |
| | Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety. | Q40860125 |
| | Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison | Q40879417 |
| | Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI? | Q41018460 |
| | Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry | Q41063266 |
| | Emergency percutaneous treatment of arterial iliac axis ruptures | Q42010557 |
| | Successful endovascular management of an aortic rupture following stent placement for severe atherosclerotic stenosis: A case report | Q42103929 |
| | Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the Prostar system in 118 cases | Q42599418 |
| | Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve | Q43882019 |
| | A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty | Q43944268 |
| | Transcatheter aortic-valve replacement for inoperable severe aortic stenosis | Q43997203 |
| | Transcatheter aortic-valve replacement with a self-expanding prosthesis | Q44094558 |
| | Transfemoral aortic valve implantation new criteria to predict vascular complications | Q44345250 |
| | Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. | Q44746086 |
| | Predicting vascular complications during transfemoral transcatheter aortic valve replacement using computed tomography: a novel area-based index | Q44908341 |
| | Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. | Q44958516 |
| | Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis | Q46294750 |
| | Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). | Q46724486 |
| | Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point | Q46750174 |
| | Impact on prognosis of periprocedural bleeding after TAVI: mid-term follow-up of a multicenter prospective study. | Q46856251 |
| | United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex | Q47618559 |
| | Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion | Q48100921 |
| | Safety and efficacy of using the Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation. | Q48105060 |
| | Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement | Q50243294 |
| | Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. | Q50567667 |
| | Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. | Q50794487 |
| | The adjunctive use of Angio-Seal in femoral vascular closure following percutaneous transcatheter aortic valve replacement. | Q50853647 |
| | First case of a left atrial dissection after transcatheter aortic valve replacement. | Q50910051 |
| | Transapical minimally invasive aortic valve implantation: multicenter experience. | Q50914393 |
| | Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. | Q51318717 |
| | Efficacy of a balloon-expandable vascular access system in transfemoral TAVI patients. | Q51406130 |
| | Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry | Q51542176 |
| | Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. | Q51673331 |
| | Vascular complications of cardiac catheterization. | Q51706804 |
| | Rates of vascular access use in transcatheter aortic valve replacement: A look into the next generation. | Q51816613 |
| | Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. | Q53181925 |
| | Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. | Q53310506 |
| | Excellent outcomes for transcatheter aortic valve replacement within 1 year of opening a low-volume centre and consideration of requirements. | Q53380144 |
| | Ultrasound first, second, and last for vascular access. | Q53518709 |
| | Clinical Outcomes Using a New Crossover Balloon Occlusion Technique for Percutaneous Closure After Transfemoral Aortic Valve Implantation | Q57741465 |
| | 2-Year Results of CoreValve Implantation Through the Subclavian Access | Q57763727 |
| | Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement | Q57914087 |
| | Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials | Q57916616 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aorta | Q101004 |
| | transcatheter aortic valve replacement | Q7167196 |
| P304 | page(s) | 234-244 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | Vascular Medicine | Q7916445 |
| P1476 | title | Vascular complications associated with transcatheter aortic valve replacement | |
| P478 | volume | 22 | |